Home / Inspections / 1116270

FDA Inspection 1116270 — New York Blood Center, Inc.

New York Blood Center, Inc. — FEI 3010484696

The FDA completed an inspection of New York Blood Center, Inc. on January 24, 2020 in Paramus, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 24, 2020
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Paramus, NJ (United States)

Facility

Other inspections at this facility

  • 1262513 (NAI Wed Feb 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1069126 (NAI Tue Sep 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 988938 (NAI Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 854859 (NAI Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources